Bausch + Lomb Will Release Third-Quarter 2022 Financial Results on November 2

Rhea-AI Summary

Bausch + Lomb (NYSE/TSX: BLCO) will announce its third-quarter 2022 financial results on November 2, 2022, at 8:00 a.m. ET. A conference call and live webcast will follow, providing insights and updates on the company's performance. Interested parties can access the webcast on the company's website. Bausch + Lomb, a global leader in eye health with over 400 products, continues to focus on enhancing vision care and maintaining a strong market presence in nearly 100 countries.

Positive

• Upcoming release of Q3 2022 financial results, indicating ongoing transparency.
• Scheduled conference call to discuss results and business updates.

Negative

• None.

VAUGHAN, ON, Oct. 4, 2022 /PRNewswire/ -- Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb"), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter 2022 financial results on Wednesday, Nov. 2, 2022. Bausch + Lomb will host a conference call and live web cast at 8:00 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the call.

Conference Call Details

Date:	Wednesday, Nov. 2, 2022
Time:	8:00 a.m. ET
Webcast:	https://www.webcaster4.com/Webcast/Page/2883/46606
Participant Event Dial-in:	+1 (888) 506-0062 (North America) +1 (973) 528-0011 (International)
Participant Access Code:	918898
Replay Dial-in:	+1 (877) 481-4010 (North America) +1 (919) 882-2331 (International)
Replay Passcode:	46606 (replay available until Nov. 16, 2022)

 

About Bausch + Lomb

Bausch + Lomb is dedicated to protecting and enhancing the gift of sight for millions of people around the world – from the moment of birth through every phase of life. Its comprehensive portfolio of more than 400 products includes contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, over-the-counter products and ophthalmic surgical devices and instruments. Founded in 1853, Bausch + Lomb has a significant global research and development, manufacturing and commercial footprint with more than 12,000 employees and a presence in nearly 100 countries. Bausch + Lomb is headquartered in Vaughan, Ontario with corporate offices in Bridgewater, New Jersey. For more information, visit www.bausch.com and connect with us on Twitter, LinkedIn, Facebook and Instagram.

© 2022 Bausch & Lomb Incorporated or its affiliates.

Investor Contacts:	Media Contacts:
Arthur Shannon	Lainie Keller
Arthur.shannon@bausch.com	lainie.keller@bausch.com
	(908) 927-1198
Allison Ryan
allison.ryan@bausch.com	Kristy Marks
(877) 354-3705 (toll free)	kristy.marks@bausch.com
(908) 927-0735	(908) 927-0683

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bausch--lomb-will-release-third-quarter-2022-financial-results-on-november-2-301639321.html

SOURCE Bausch + Lomb Corporation

FAQ

What date will Bausch + Lomb release its Q3 2022 financial results?

Bausch + Lomb will release its Q3 2022 financial results on November 2, 2022.

What time is the Bausch + Lomb conference call scheduled?

The conference call is scheduled for 8:00 a.m. ET.

How can I access the Bausch + Lomb Q3 2022 financial results call?

The call can be accessed via a live webcast available on Bausch + Lomb's Investor Relations website.

What is the stock symbol for Bausch + Lomb?

The stock symbol for Bausch + Lomb is BLCO.

What type of products does Bausch + Lomb offer?

Bausch + Lomb offers a comprehensive portfolio of over 400 products, including contact lenses and eye care products.